Articles/Commentaries
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials by Toby M. Maher, MD, PhD, Paul Ford, MD, PhD, Kevin K. Brown, MD, et al. JAMA May 9 2023